In summary, cirrhosis, male sex, and obesity are key risk factors for HCC in patients with CHB, while dyslipidemia treated with statins, higher platelet counts, and serum albumin levels are associated with reduced risk. This evidence concerns the gene ALB and metabolic syndrome.